Rights and permissions
About this article
Cite this article
OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth. Inpharma Wkly. 1294, 9 (2001). https://doi.org/10.2165/00128413-200112940-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112940-00018